From January 23 to 24, 2024, the 13th Charity Festival and 2023 ESG Impact Annual Conference, one of the most well-known and influential annual events in the field of philanthropy in China, was held in Beijing. Huaxia Ophthalmology stood out with its active exploration and innovative practice in ESG construction and won the "2023 ESG Pioneer Enterprise Award".
It is reported that the Charity Festival was established in 2011 and is the first festival named after "Charity" jointly initiated by the public in China, aiming to promote the spirit of public welfare and guide a healthy public welfare culture. After 13 years of accumulation and precipitation, the overall spread and coverage of the event exceeded 100 million people.
The "ESG Pioneer Enterprise Award" is intended to recognize advanced enterprises that pay equal attention to economic efficiency and social responsibility, and is a high recognition of the work of enterprises in environmental protection, social responsibility and corporate governance.
This award is not only a recognition of Huaxia Ophthalmology's ESG development concept, but also an affirmation of the Group's continuous innovation and deepening on the road of sustainable development.
A new stage of charging
The ESG construction of Huaxia Ophthalmology has been comprehensively deepened
As a large-scale ophthalmic medical chain group in China, Huaxia Ophthalmology has always attached great importance to sustainable development, and after its successful listing, it has taken the initiative to integrate ESG concepts into its corporate development strategy and comprehensively deepened it, continuously improving its ESG management structure, diversifying and comprehensive ESG practices, and enriching and diverse innovation achievements, and has embarked on a road of ESG construction with Huaxia development characteristics.
Anchor the overall situation and formally build an ESG management structure. In order to further improve the corporate governance structure, implement and enhance the company's environmental, social and governance (ESG) work, and enhance the company's core competitiveness and sustainable development capabilities, in October 2023, Huaxia Ophthalmology changed the name of the strategy committee of the board of directors to the strategy and sustainable development committee of the board of directors, providing overall and scientific guidance and supervision for the formulation and implementation of ESG strategy, and firmly infiltrating the concept of sustainable development into business operations.
With top-down efforts, the Group has achieved remarkable results in ensuring medical quality and product safety, medical waste management, protecting patient privacy, and helping employees learn and grow, not only providing patients with safer and high-quality diagnosis and treatment services, but also injecting stronger endogenous power into the high-quality development of the enterprise.
Continuous goodness, ESG practices are diverse and comprehensive. In 2023, Huaxia Ophthalmology will continue to make great strides on the road of public welfare, and "* Bright Walk" will complete the myopia, strabismus and amblyopia screening of 10,741 primary and secondary school students in 13 schools in the first district and four counties of Shigatse City, provide free glasses for more than 1,000 children, and donate high-value medical consumables and glasses with a total value of 3 million yuan; During the "Cambodia International Brightness Tour", the medical team screened a total of 3,589 patients and completed 564 cataract surgeries.
In view of the high myopia rate of children and adolescents in China, and the increasingly severe situation of young age and severity, Huaxia Ophthalmology independently developed the "Vision Quick Screening Information Technology", and upgraded and launched the "Huaxia Ophthalmology 365 Proximity Prevention Model" based on new technologies, and cared for the eye health of children and adolescents through public welfare activities such as "Angel Bright Eyes, Pupil Love Action" and "Overseas Chinese Love, Rural Student Optometry Project", and helped achieve the goals of the "14th Five-Year Plan" eye health plan.
Spreading light with superb medical skills, giving back to the society with responsibility and responsibility, so that more people can enjoy fair, accessible, high-quality and inclusive eye health medical services, Huaxia Ophthalmology is striving to benefit more patients with eye diseases with heavy ESG results.
Talent cultivation and continuous ESG innovation. Talent is an important cornerstone of sustainable development of enterprises, and it is also the key to continuous innovation in ESG. In 2023, Huaxia Ophthalmology will continue to improve the talent cultivation system, on the one hand, on the basis of establishing cooperative relations with more than 30 colleges and universities such as Peking University and Xiamen University, it will further promote the pace of school-enterprise cooperation and co-construction, and sign contracts with Xiamen University School of Medicine, Dali University and other universities to start strategic cooperation to jointly promote the integrated development of industry, university and research; On the other hand, we continue to hold talent cultivation programs such as the China Ophthalmologist Rising Star Program and the China Ophthalmologist Elite Talent Program, continuously cultivate professional ophthalmology talents, and strive to build a talent learning and exchange platform, and actively participate in well-known academic conferences at home and abroad, so as to contribute "Huaxia Wisdom" to academic and scientific research breakthroughs in the ophthalmology community and help the sustainable and high-quality development of the industry.
From originating in Xiamen to managing 67 ophthalmology hospitals and 53 optometry centers in 21 provinces (municipalities directly under the central government) and 55 cities across the country, Huaxia Ophthalmology's strides forward are the best portrayal of Huaxia Ophthalmology's emphasis on sustainable development over the years. As a pioneer in ESG construction in the field of ophthalmology in China, Huaxia Ophthalmology has the courage to explore and research, dare to innovate and make breakthroughs, and its ESG brand influence has been initially revealed, and it has successively won awards and recognition such as "ESG Best Social Responsibility Practice Enterprise", "Annual Public Welfare Enterprise" and "Social Responsibility Pioneer Enterprise".
Honor is not only an affirmation of past achievements, but also an incentive for future development. Facing the future, Huaxia Ophthalmology will continue to be guided by ESG, continue to enhance the importance, comprehensiveness, systematization and in-depth nature of ESG construction, strive to improve the level of sustainable development, continue to create sustainable value, and inject more long-term development momentum into the "Centennial Huaxia".